Dova's thrombocytopenia drug gets its first approval from FDA

FDA approved Doptelet avatrombopag from the AkaRx Inc. subsidiary of Dova Pharmaceuticals Inc. (NASDAQ:DOVA) to treat thrombocytopenia in adults with chronic liver disease who are scheduled to

Read the full 279 word article

User Sign In